Skip to main content
. 2014 Dec 6;9(11):1446–1453. doi: 10.4161/15592294.2014.971626

Table 1.

Clinicopathological parameters recorded from 40 NSCLC patients. Adeno, Adenocarcinoma; SCCA, Squamous Cell Carcinoma; M, Methylated; U, Unmethylated; 1, Cisplatin-Vinorelbine; 2, Carboplatin-Vinorelbine; 3, Cisplatin-Gemcitabine; 4, Carboplatin-Paclitaxel

Patient Methylation levels (IGFBP3/ACTB)*1000 Methylation status Age, y Sex Histology Stage (TNM) Chemotherapy Radiotherapy Start of Chemotherapy End of Chemotherapy Last contact Status
1 496.148 M 58 Female Adeno IIIB 4 Yes 2002-06-20 2002-08-08 2003-07-19 Exitus
2 210.679 M 70 Female SCCA IIIA 1 No 2009-01-20 2009-04-14 2012-01-27 Alive
3 62.698 M 70 Female SCCA IB 1 No 2005-08-25 2005-09-22 2006-07-25 Exitus
4 18.000 M 65 Female SCCA IB 1 No 2009-05-26 2009-07-14 2012-05-08 Alive
5 15.546 M 61 Female Adeno IV 1 Yes 2009-02-26 2009-05-07 2012-05-17 Alive
6 7.550 M 73 Male Adeno IIIA 1 Yes 2007-09-17 2007-09-25 2012-02-09 Alive
7 4.377 M 70 Female SCCA IB 1 No 2006-05-11 2006-07-27 2006-10-05 Exitus
8 3.845 M 56 Female Adeno IIIA 2 No 2006-06-29 2006-09-07 2011-11-08 Alive
9 3.100 M 63 Female Adeno IIIA 1 Yes 2009-06-29 2009-09-07 2012-04-16 Alive
10 2.593 M 63 Female SCCA IV 1 No 2005-07-28 2005-08-26 2005-10-01 Exitus
11 2.088 M 68 Female Adeno IIA 1 No 2006-11-16 2007-01-25 2012-04-18 Alive
12 1.915 M 54 Female Adeno IIB 1 No 2009-12-14 2010-02-22 2012-05-31 Alive
13 1.507 M 56 Female Adeno IIB 1 No 2008-12-23 2009-03-12 2012-02-02 Alive
14 0.670 M 72 Female Adeno IIIA 2 Yes 2010-10-14 2010-12-02 2011-03-01 Exitus
15 0.555 U 63 Female Adeno IIB 1 Yes 2009-06-08 2009-08-17 2012-06-04 Alive
16 0.514 U 65 Female Large Cell IIIB 4 Yes 2006-01-02 2006-03-06 2006-04-18 Exitus
17 0.511 U 72 Female Large Cell IIIA 3 Yes 2003-01-30 2003-03-26 2004-04-24 Exitus
18 0.439 U 59 Female Large Cell IIIA 1 No 2005-11-24 2006-01-19 2012-01-18 Alive
19 0.169 U 79 Female Adeno IIIB 2 Yes 2008-04-11 2008-05-30 2011-09-16 Alive
20 0.077 U 69 Female Adeno IIIA 1 No 2010-03-23 2010-06-08 2011-08-21 Exitus
21 0.001 U 70 Male Adeno IB 1 No 2006-06-01 2006-07-20 2011-05-09 Alive
22 0.001 U 56 Female SCCA IIIA 1 No 2006-03-09 2006-05-22 2007-12-29 Exitus
23 0 U 72 Female SCCA IB 3 No 2006-01-19 2006-03-30 2007-12-13 Exitus
24 0 U 65 Female Adeno IIA 3 No 2007-01-26 2007-02-02 2012-06-14 Alive
25 0 U 67 Female SCCA IIIB 2 No 2009-04-16 2009-06-30 2012-03-30 Alive
26 0 U 75 Male Adeno II 2 No 2006-05-18 2006-07-27 2012-05-16 Alive
27 0 U 47 Male Adeno IB 1 No 2007-07-20 2007-09-07 2012-06-14 Alive
28 0 U 52 Male Adeno IIB 1 No 2007-08-06 2007-10-08 2012-04-20 Alive
29 0 U 61 Female Adeno IIIA 1 No 2007-12-03 2008-02-18 2009-02-12 Alive
30 0 U 73 Female Adeno IIIA 2 Yes 2009-10-01 2009-11-19 2010-03-23 Alive
31 0 U 55 Female Adeno IIB 1 No 2010-01-21 2010-04-06 2012-03-15 Alive
32 0 U 64 Female SCCA IIB 1 No 2010-01-22 2010-04-01 2012-05-21 Alive
33 0 U 69 Male Adeno IIIA 4 Yes 2002-06-13 2002-08-16 2006-05-17 Exitus
34 0 U 52 Female Adeno IB 3 No 2002-06-28 2002-08-26 2008-06-22 Exitus
35 0 U 61 Female SCCA IIB 3 No 2004-10-07 2004-12-23 2007-04-08 Exitus
36 0 U 50 Female SCCA IB 1 No 2008-03-17 2008-05-26 2010-03-06 Exitus
37 0 U 67 Female SCCA IIB 1 Yes 2009-05-28 2009-08-31 2009-11-23 Exitus
38 0 U 69 Female Adeno IIIA 1 No 2010-03-23 2010-06-08 2011-08-21 Exitus
39 0 U 57 Female Adeno IIIB 3 No 1999-05-07 1999-07-21 2005-05-17 Exitus
40 0 U 57 Female Adeno IIIA 4 Yes 2002-04-12 2002-05-23 2002-11-29 Exitus